QC
NAUT icon

Quadrature Capital’s Nautilus Biotechnolgy NAUT Stock Holding History

Quadrature Capital’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$110K Buy
+58,559
New +$155K ﹤0.01% 1456

Other funds holding NAUT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return
ST
Sentinel Trust Houston, Texas $1.13B AUM 24.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HC
Hillman Company Pittsburgh, Pennsylvania $283M AUM 23.82% 1-Year Est. Return
CA
Crewe Advisors Salt Lake City, Utah $1.38B AUM 41.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $8.3B AUM 27.66% 1-Year Est. Return

Quadrature Capital's NAUT Position: Q2 2026 in Review

Quadrature Capital opened a new position in Nautilus Biotechnolgy (NAUT) in Q2 2026: 58,559 shares worth $110K. The stake represents ﹤0.01% of the portfolio and ranks #1456 among its holdings.

30 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • Quadrature Capital held 58,559 shares of Nautilus Biotechnolgy worth $110K as of Q2 2026.
  • Nautilus Biotechnolgy was a new Quadrature Capital position in Q2 2026.
  • Nautilus Biotechnolgy made up ﹤0.01% of Quadrature Capital's portfolio in Q2 2026, its #1456 holding.
  • 30 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.